Roche Submits PMA Supplement To FDA For Cobas HPV Test – RTT News

Roche Submits PMA Supplement To FDA For Cobas HPV Test
RTT News
Approval of the expanded indication would mean the cobas HPV Test could be used as the first-line test rather than Pap cytology as part of a cervical cancer screening strategy. The filing includes new three-year follow-up data from the ATHENA study, 
Roche submits filing to FDA for cervical cancer primary screening indication MarketWatch (press release)

all 4 news articles »

View full post on hpv – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *